---
trial_id: 474
discovery_date: 2022-04-05 21:16:14.422273
date: 2022-04-05 21:16:14.422273
title: "A Multinational, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Once Daily Oral Administration of Laquinimod (..."
summary: |
  <p>EudraCT Number: 2014-001579-30<br />Sponsor Protocol Number: TV5600-CNS-20006<br />Sponsor Name: Teva Pharmaceutical Industries Ltd.<br />Start Date: 2014-11-27<br />Medical condition: Primary Progressive Multiple Sclerosis<br />Disease: <br />Version: 19.0<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063401<br />Term: Primary progressive multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001579-30/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001579-30/IT">IT</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001579-30/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001579-30/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001579-30/NL">NL</a> (Completed)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-001579-30'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2014-001579-30<br />Sponsor Protocol Number: TV5600-CNS-20006<br />Sponsor Name: Teva Pharmaceutical Industries Ltd.<br />Start Date: 2014-11-27<br />Medical condition: Primary Progressive Multiple Sclerosis<br />Disease: <br />Version: 19.0<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063401<br />Term: Primary progressive multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001579-30/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001579-30/IT">IT</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001579-30/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001579-30/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2014-001579-30/NL">NL</a> (Completed)</p>